Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunoregulation by members of the TGFβ superfamily
Wanjun Chen, Peter ten Dijke
Nature reviews. Immunology (2016) Vol. 16, Iss. 12, pp. 723-740
Closed Access | Times Cited: 308

Showing 1-25 of 308 citing articles:

Transforming Growth Factor-β Signaling in Immunity and Cancer
Eduard Batlle, Joan Massagué
Immunity (2019) Vol. 50, Iss. 4, pp. 924-940
Open Access | Times Cited: 1751
Targeting TGF-β Signaling in Cancer
Selçuk Çolak, Peter ten Dijke
Trends in cancer (2017) Vol. 3, Iss. 1, pp. 56-71
Closed Access | Times Cited: 865
TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis
Hao Yang, D.A. Baker, Peter ten Dijke
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 11, pp. 2767-2767
Open Access | Times Cited: 850
Contextual determinants of TGFβ action in development, immunity and cancer
Charles J. David, Joan Massagué
Nature Reviews Molecular Cell Biology (2018) Vol. 19, Iss. 7, pp. 419-435
Open Access | Times Cited: 675
GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand
Linda Yang, Chih-Chuan Chang, Zhe Sun, et al.
Nature Medicine (2017) Vol. 23, Iss. 10, pp. 1158-1166
Closed Access | Times Cited: 544
The hallmarks of successful anticancer immunotherapy
Lorenzo Galluzzi, Timothy A. Chan, Guido Kroemer, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 459
Open Access | Times Cited: 491
EMT and inflammation: inseparable actors of cancer progression
Meggy Suarez‐Carmona, Julien Lesage, Didier Cataldo, et al.
Molecular Oncology (2017) Vol. 11, Iss. 7, pp. 805-823
Open Access | Times Cited: 487
Glioma targeted therapy: insight into future of molecular approaches
Keyang Yang, Zhijing Wu, Hao Zhang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 476
TGF-β Signaling in Lung Health and Disease
Akira Saito, Masafumi Horie, Takahide Nagase
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 8, pp. 2460-2460
Open Access | Times Cited: 396
Nutrition, inflammation and cancer
Laurence Zitvogel, Federico Pietrocola, Guido Kroemer
Nature Immunology (2017) Vol. 18, Iss. 8, pp. 843-850
Closed Access | Times Cited: 365
Modulation of Host Immunity by Helminths: The Expanding Repertoire of Parasite Effector Molecules
Rick M. Maizels, Hermelijn H. Smits, Henry J. McSorley
Immunity (2018) Vol. 49, Iss. 5, pp. 801-818
Open Access | Times Cited: 359
Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment
Lin Chen, Tian Yang, Dewen Lu, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 101, pp. 670-681
Open Access | Times Cited: 293
Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment
Mansi Saxena, Nina Bhardwaj
Trends in cancer (2018) Vol. 4, Iss. 2, pp. 119-137
Open Access | Times Cited: 263
Targeting TGFβ signal transduction for cancer therapy
Sijia Liu, Jiang Ren, Peter ten Dijke
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 260
Understanding the tumor microenvironment for effective immunotherapy
Habib Sadeghi Rad, James Monkman, Majid Ebrahimi Warkiani, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 3, pp. 1474-1498
Open Access | Times Cited: 230
A pulsatile release platform based on photo-induced imine-crosslinking hydrogel promotes scarless wound healing
Jian Zhang, Yongjun Zheng, Jimmy Lee, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 228
Targeting TGF-β signaling for the treatment of fibrosis
Andrea‐Hermina Györfi, Alexandru‐Emil Matei, Jörg H. W. Distler
Matrix Biology (2018) Vol. 68-69, pp. 8-27
Closed Access | Times Cited: 226
Overcoming TGFβ-mediated immune evasion in cancer
Daniele V. F. Tauriello, Elena Sancho, Eduard Batlle
Nature reviews. Cancer (2021) Vol. 22, Iss. 1, pp. 25-44
Open Access | Times Cited: 221
Immunomodulatory TGF-β Signaling in Hepatocellular Carcinoma
Jian Chen, Julian A. Gingold, Xiaoping Su
Trends in Molecular Medicine (2019) Vol. 25, Iss. 11, pp. 1010-1023
Open Access | Times Cited: 217
Bispecific antibodies in cancer immunotherapy
Eva Dahlén, Niina Veitonmäki, Per Norlén
Therapeutic Advances in Vaccines and Immunotherapy (2018) Vol. 6, Iss. 1, pp. 3-17
Open Access | Times Cited: 184
Turning up the heat on non-immunoreactive tumours: opportunities for clinical development
María Ochoa de Olza, Blanca Navarro Rodrigo, Stefan Zimmermann, et al.
The Lancet Oncology (2020) Vol. 21, Iss. 9, pp. e419-e430
Closed Access | Times Cited: 178
Cytokines in Male Fertility and Reproductive Pathologies: Immunoregulation and Beyond
Kate L. Loveland, Britta Klein, Dana Pueschl, et al.
Frontiers in Endocrinology (2017) Vol. 8
Open Access | Times Cited: 171
Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy
Shan Gao, Dongjuan Yang, Yan Fang, et al.
Theranostics (2018) Vol. 9, Iss. 1, pp. 126-151
Open Access | Times Cited: 166
Activin A in Mammalian Physiology
Enrrico Bloise, Pasquapina Ciarmela, Cynthia Dela Cruz, et al.
Physiological Reviews (2018) Vol. 99, Iss. 1, pp. 739-780
Open Access | Times Cited: 165
Recent advances in systemic therapy for hepatocellular carcinoma
Huajun Zhang, Wuyang Zhang, Longying Jiang, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 162
Page 1 - Next Page

Scroll to top